Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns naming Pádraig O'Sullivan .
Filed returns
463
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2023 | LGBT Support and Advocacy Network Ireland CLG | Health | Health (Assisted Human Reproduction) Bill 2022 (Legislation) | 198 | On lobbying.ie |
| Jan–Apr 2023 | Janssen Sciences Ireland UC | Health | Sharing Invite to discussion series on 'Ireland & the European Health Union Series: What will it mean for rare disease'' (Public policy or programme) | 15 | On lobbying.ie |
| Jan–Apr 2023 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 6 | On lobbying.ie |
| Jan–Apr 2023 | Q4PR | Health | Breifing on the work of Stryker in Ireland (Public policy or programme) | 9 | On lobbying.ie |
| Jan–Apr 2023 | Fighting Blindness | Health | The HSE reimbursement of gene therapy 'Luxturna' (Matters involving public funds) | 3 | On lobbying.ie |
| Jan–Apr 2023 | JTI Ireland Limited | Health | Oral smokeless tobacco products in Ireland (Legislation) | 4 | On lobbying.ie |
| Jan–Apr 2023 | Hanover Media Strategy Limited | Health | Rare Disease Policy (Legislation) | 17 | On lobbying.ie |
| Jan–Apr 2023 | Vertex Pharmaceuticals (Europe) Limited | Health | Access to cystic fibrosis medicines in Ireland (Public policy or programme) | 27 | On lobbying.ie |
| Jan–Apr 2023 | Novartis Ireland Limited | Health | Expension of the newborn screening program - adding more diseases to the heel prick test (Matters involving public funds) | 3 | On lobbying.ie |
| Jan–Apr 2023 | SPINAL MUSCULAR ATROPHY IRELAND FOUNDATION CLG | Health | Rare diseases and newborn screening of babies (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2023 | Vulcan Consulting Limited | Health | EU Pharmaceutical Strategy (Public policy or programme) | 12 | On lobbying.ie |
| Jan–Apr 2023 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2022 | Autism Spectrum Information, Advice and Meeting Point Ltd, Trading as AsIAm | Health | Engaged with members of the Oireachtas Committee on Autism (Public policy or programme) | 14 | On lobbying.ie |
| Sep–Dec 2022 | National Women's Council of Ireland | Health | Every Woman Report: reproductive health (Public policy or programme) | 28 | On lobbying.ie |
| Sep–Dec 2022 | Rare Diseases Ireland | Health | Invitation to attend Rare Diseases Ireland Round Table of Companies meeting to discuss EU action in the rare disease policy and programmes. (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2022 | Rare Diseases Ireland | Health | Support for establishment of cross-party rare diseases group (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2022 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | High Tech medicines policy in Ireland (Legislation) | 4 | On lobbying.ie |
| Sep–Dec 2022 | BioMarin International Limited | Health | Rare Disease Policy in Ireland (Legislation) | 13 | On lobbying.ie |
| Sep–Dec 2022 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2022 | Irish Hospital Consultants Association | Health | Pre-budget submission concerning the 2023 health budget on increased capacity and resourcing needs of acute hospital and mental health services, recruitment and retention of consultants, and clinical indemnity. (Matters involving public funds) | 106 | On lobbying.ie |
| Sep–Dec 2022 | Vulcan Consulting Limited | Health | EU Pharmaceutical Strategy (Public policy or programme) | 21 | On lobbying.ie |
| Sep–Dec 2022 | Irish Pharmaceutical Healthcare Association | Health | EU Policy matters and fast access for new and innovative medicines. (Public policy or programme) | 5 | On lobbying.ie |
| Sep–Dec 2022 | Irish Pharmaceutical Healthcare Association | Health | Medicines innovation - Arrange meeting with LIF (Danish biopharmaceutical association) to discuss policy matters in relation to medicines innovation (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2022 | Janssen Sciences Ireland UC | Health | Sharing Invite to discussion series on 'Ireland & the European Health Union Series: Opportunities to Improve Irish Healthcare' (Public policy or programme) | 23 | On lobbying.ie |
| Sep–Dec 2022 | MSD | Health | Reimbursement of innovative oncology medicines and establishment of a National Medicines Agency (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2022 | MSD | Health | Launch of research report on socio-economic inequalities in cancer (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2022 | COPD Support Ireland | Health | Presentation about COPD and the work of COPD Support Ireland in the AV room of Oireachtas. (Public policy or programme) | 11 | On lobbying.ie |
| Sep–Dec 2022 | Gibney Communications | Health | To highlight the need for greater public information and education to reduce the misuse of alcohol in Ireland. (Public policy or programme) | 25 | On lobbying.ie |
| Sep–Dec 2022 | Irish Association for Counselling and Psychotherapy - IACP | Health | Counselling In Schools Programme/Pilot (Legislation) | 36 | On lobbying.ie |
| Sep–Dec 2022 | Vertex Pharmaceuticals (Europe) Limited | Health | Meeting to discuss access to cystic fibrosis medicines in Ireland (Public policy or programme) | 25 | On lobbying.ie |
| Sep–Dec 2022 | Multiple Sclerosis Ireland | Health | Multiple Sclerosis Ireland sent a Christmas card to a number of Oireachtas members to thank them for their support in 2022 and ask that they continue to support MS Ireland in 2023 (Matters involving public funds) | 49 | On lobbying.ie |
| Sep–Dec 2022 | Multiple Sclerosis Ireland | Health | The Multiple Sclerosis Society of Ireland thanked Oireachtas members for their attendance at our AV room briefing and requested they continue their support for our Pre-Budget Asks (Matters involving public funds) | 21 | On lobbying.ie |
| Sep–Dec 2022 | Multiple Sclerosis Ireland | Health | Multiple Sclerosis Ireland invited all Oireachtas members to support their Pre-Budget Submission by attending their AV room briefing (Matters involving public funds) | 28 | On lobbying.ie |
| Sep–Dec 2022 | Pro Life Campaign | Health | Letter to Fianna Fáil elected representatives following FF Ard Fheis (Public policy or programme) | 44 | On lobbying.ie |
| Sep–Dec 2022 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 21 | On lobbying.ie |
| Sep–Dec 2022 | Irish Platform for Patients' Organisations, Science and Industry | Health | Invited Deputy Padraig O'Sullivan to speak at the (online) Third Rare Disease Forum, 28 November 2022 (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2022 | Hanover Media Strategy Limited | Health | Rare Disease Policy (Legislation) | 9 | On lobbying.ie |
| Sep–Dec 2022 | Novartis Gene Therapies Gmbh | Health | Novartis Gene Therapies financially supported an event organised by SMA Ireland in the Mansion House to advocate for the addition of more rare diseases to Ireland’s newborn screening programme. The event coincided with… (Public policy or programme) | 112 | On lobbying.ie |
| May–Aug 2022 | MSD | Health | Access to Medicines (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2022 | Autism Spectrum Information, Advice and Meeting Point Ltd, Trading as AsIAm | Health | Wrote to members of the Oireachtas Autism, Health and Disability Matters Committee expressing our concern at the proposal to exclude Autistic people from the CAMHS prescribing audit (Public policy or programme) | 33 | On lobbying.ie |
| May–Aug 2022 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | High Tech medicines policy in Ireland (Legislation) | 5 | On lobbying.ie |
| May–Aug 2022 | Vertex Pharmaceuticals (Europe) Limited | Health | Meeting to discuss access to cystic fibrosis medicines in Ireland (Public policy or programme) | 35 | On lobbying.ie |
| May–Aug 2022 | Rare Diseases Ireland | Health | Support for establishment of cross-party rare diseases group (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2022 | Rare Diseases Ireland | Health | Commentary re Health Committee meeting of 22 Jun (Public policy or programme) | 14 | On lobbying.ie |
| May–Aug 2022 | Rare Diseases Ireland | Health | Letter requesting support for National Screening Advisory Committee Bill 2020 (Legislation) | 18 | On lobbying.ie |
| May–Aug 2022 | BioMarin International Limited | Health | Rare disease policy in Ireland and EU (Public policy or programme) | 24 | On lobbying.ie |
| May–Aug 2022 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 23 | On lobbying.ie |
| May–Aug 2022 | Pfizer | Health | Pfizer COVID-19 anti-viral treatment (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2022 | Pfizer | Health | PMB re orphan medicines, Health (Pricing and Supply of Medical Goods) (Amendment) Bill 2021 (Legislation) | 1 | On lobbying.ie |
| May–Aug 2022 | Gilead Sciences Ireland UC | Health | HIV, Hepatitis-C & Oncology healthcare policy and access to lifesciences innovation in Ireland (Matters involving public funds) | 2 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 463 | 100.0% |